Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PurHealthRX is a private health and wellness company focused on hemp-derived CBD products and bioavailability-enhancing formulation technology. The company manufactures, distributes, and sells full-spectrum hemp CBD oil products using its proprietary Purzorb technology, which converts oil-based ingredients into water-soluble or bioavailable formulations. Its products have been marketed under the Pur 7 and Med 7 brands, and its formulation technology has also been marketed as Biosorb in products sold through Q Sciences. Publicly available materials emphasize commercial wellness products rather than a traditional prescription-drug development pipeline, although the company has publicized human studies of its CBD formulations in areas such as anti-aging and sleep. Overall, PurHealthRX appears to operate at the intersection of consumer health, nutraceuticals, and cannabinoid-enabled wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PurHealthRX.